ArticleMarine drugs2025

Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways.

Jing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.